Advocated for funding for CDC's Infectious Diseases and Opioid Epidemic program in the FY24 Labor, Health and Human Services, Education and Related Agencies (LHHS) appropriations bill to support strategies that prevent drug overdose and reduce harms related to drug use, including infectious diseases transmission. Also requested the removal of the ban on using federal funds for the purchase of syringes in the FY24 LHHS appropriations bill.
Conducted educational meetings regarding public health strategies to prevent overdose and reduce the harms of drug use.
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2023: U.S. Senate, House of Representatives, Office of Natl Drug Control Policy (NDCP), Substance Abuse & Mental Health Services Administration (SAMHSA)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Termination
Q4 Report
Q3 Report
Q2 Report
Registration
Q1 Report
Registration
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate
Searching...